EQUITY, STOCK-BASED COMPENSATION AND EARNINGS (LOSS) PER SHARE - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		9 Months Ended
	Mar. 13, 2025	Dec. 30, 2024	Dec. 30, 2024	Dec. 18, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Sep. 30, 2024	Mar. 14, 2024	Nov. 04, 2021	Nov. 03, 2021
Stockholders equity and income (loss) per share
Common and preferred stock authorized (in shares)											75,000,000	20,000,000
Common stock authorized (in shares)					74,000,000		74,000,000		74,000,000		74,000,000	19,000,000
Preferred stock authorized (in shares)											1,000,000	1,000,000
Preferred stock outstanding (in shares)					0		0		0
Proceeds from issuance of common stock		$ 27,524					$ 27,524	$ 0
Stock based compensation expense					$ 1,439	$ 1,337	$ 4,644	$ 5,118
Warrants
Stockholders equity and income (loss) per share
Warrants exercise price (in usd per share)					$ 1.57		$ 1.57
Warrants exchanged (in shares)							1,112,126
Stock issued in exchange of warrants exercised (in shares)							801,013
Underwriting Agreement
Stockholders equity and income (loss) per share
Shares issued in public offering (in shares)				6,000,000
Share purchase price ( in usd per share)				$ 4.25
Over-Allotment Option
Stockholders equity and income (loss) per share
Shares issued in public offering (in shares)			900,000
Option to purchase additional shares				30 days
the “2024 Plan”
Stockholders equity and income (loss) per share
Shares authorized for issuance (shares)										1,500,000
Number of shares remained available for grants (in shares)					914,941		914,941
Additional shares authorized under plan (in shares)	2,250,000